Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 9Breast Neoplasms 5Uterine Cervical Neoplasms 4Gliosarcoma 4Glioma 4Glioblastoma 4Ganglioneuroblastoma 4Pancreatic Neoplasms 3Neuroblastoma 3Vaginal Neoplasms 2Thyroid Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma, Ewing 2Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Oligodendroglioma 2Lung Neoplasms 2Glioma, Subependymal 2Ependymoma 2Cholangiocarcinoma 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Astrocytoma 2Adenocarcinoma Of Esophagus 2Wilms Tumor 1Thyroid Diseases 1Thyroid Cancer, Papillary 1Thoracic Diseases 1

Interventions

Magnetic Resonance Spectroscopy 4olaparib 1gallium 68 PSMA-11 1durvalumab 1X-Rays 1Specimen Handling 1Radiation 1Photons 1Lutetium-177 1Immunoglobulin G 1Disulfides 1Congresses as Topic 168Ga-DKFZ-PSMA-11 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Biochemically Recurrent Prostate Carcinoma × Congresses as Topic × Clear all
NCT06105918 2025-12-09

Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer

Emory University

Phase 1 Active not recruiting
6 enrolled
Genitourinary

Biochemically Recurrent Prostate Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡